BUD13 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.107800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.407590E-01
Normal-vs-Stage2
2.972400E-01
Normal-vs-Stage3
2.039600E-01
Normal-vs-Stage4
7.149200E-01
Stage1-vs-Stage2
5.487200E-01
Stage1-vs-Stage3
4.459000E-01
Stage1-vs-Stage4
9.430000E-02
Stage2-vs-Stage3
1.478220E-01
Stage2-vs-Stage4
5.605900E-02
Stage3-vs-Stage4
1.309550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.400000E-01
Normal-vs-AfricanAmerican
2.069800E-01
Normal-vs-Asian
8.931600E-02
Caucasian-vs-AfricanAmerican
9.491600E-01
Caucasian-vs-Asian
2.985600E-01
AfricanAmerican-vs-Asian
3.219800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.034000E-01
Normal-vs-Female
3.231400E-01
Male-vs-Female
9.082200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.491380E-01
Normal-vs-Age(41-60Yrs)
4.743800E-01
Normal-vs-Age(61-80Yrs)
2.593600E-01
Normal-vs-Age(81-100Yrs)
3.530200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.436230E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.560600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.654800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.716100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.412200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.640200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.729800E-01
Normal-vs-Daily Drinker
4.401000E-01
Normal-vs-Weekly Drinker
7.102000E-02
Normal-vs-Occasional Drinker
7.224800E-01
Normal-vs-Social Drinker
3.373600E-01
Non Drinker-vs-Daily Drinker
3.790800E-01
Non Drinker-vs-Weekly Drinker
7.992800E-01
Non Drinker-vs-Occasional Drinker
2.498300E-02
Non Drinker-vs-Social Drinker
3.770400E-01
Daily Drinker-vs-Weekly Drinker
3.315400E-01
Daily Drinker-vs-Occasional Drinker
2.616200E-01
Daily Drinker-vs-Social Drinker
9.965600E-01
Weekly Drinker-vs-Occasional Drinker
1.341530E-02
Weekly Drinker-vs-Social Drinker
2.558400E-01
Occasional Drinker-vs-Social Drinker
2.193000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.474400E-01
Normal-vs-Grade 2
5.385600E-01
Normal-vs-Grade 3
2.252100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.659800E-02
Grade 1-vs-Grade 3
2.597800E-03
Grade 1-vs-Grade 4
2.474400E-01
Grade 2-vs-Grade 3
1.666240E-02
Grade 2-vs-Grade 4
5.385600E-01
Grade 3-vs-Grade 4
2.252100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.021600E-01
Normal-vs-NonDiabetic
2.682200E-01
Diabetic-vs-NonDiabetic
2.738200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.676600E-01
Normal-vs-NoPancreatitis
2.544200E-01
Pancreatitis-vs-NoPancreatitis
3.434200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.843200E-01
Normal-vs-N1
3.157400E-01
N0-vs-N1
3.022200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.745400E-01
Normal-vs-TP53-NonMutant
3.634200E-01
TP53-Mutant-vs-TP53-NonMutant
7.541200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
